Viewing Study NCT00482261


Ignite Creation Date: 2025-12-24 @ 12:20 PM
Ignite Modification Date: 2026-01-10 @ 11:43 AM
Study NCT ID: NCT00482261
Status: COMPLETED
Last Update Posted: 2024-11-08
First Post: 2007-06-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression
Sponsor: Peter MacCallum Cancer Centre, Australia
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: RV-PI-0103
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View